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Abstract
The identification of molecular biomarkers is critical for diagnosing and treating patients and for establishing a fundamental
understanding of the pathophysiology and underlying biochemistry of inborn errors of metabolism. Currently, liquid
chromatography/high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy are the principle methods
used for biomarker research and for structural elucidation of small molecules in patient body fluids. While both are powerful
techniques, several limitations exist that often make the identification of unknown compounds challenging. Here, we describe
how infrared ion spectroscopy has the potential to be a valuable orthogonal technique that provides highly-specific molecular
structure information while maintaining ultra-high sensitivity. Here, we characterize and distinguish two well-known biomarkers
of inborn errors of metabolism, glutaric acid for glutaric aciduria and ethylmalonic acid for short-chain acyl-CoA dehydrogenase
deficiency, using infrared ion spectroscopy. In contrast to tandem mass spectra, in which ion fragments can hardly be predicted,
we show that the prediction of an IR spectrum allows reference-free identification in the case that standard compounds are either
commercially or synthetically unavailable. Finally, we illustrate how functional group information can be obtained from an IR
spectrum for an unknown and how this is valuable information to, for example, narrow down a list of candidate structures
resulting from a database query. Early diagnosis in inborn errors of metabolism is crucial for enabling treatment and depends on
the identification of biomarkers specific for the disorder. Infrared ion spectroscopy has the potential to play a pivotal role in the
identification of challenging biomarkers.
Keywords Infrared ion spectroscopy . Feature identification . Biomarkers . Molecular structure analysis . Inborn errors of
metabolism . HMDB . Computational chemistry
Introduction
Many biomarkers of inherited metabolic diseases can be diag-
nosed in high-throughput targeted analyses that are often suf-
ficiently routine for large scale screening. However, the devel-
opment of such protocols requires the knowledge of diagnos-
tic biomarkers which, by definition, must be first identified in
(un)targeted analyses of patient body fluids. Currently, (ultra)
high performance liquid chromatography/high-resolution
(tandem) mass spectrometry ((U)HPLC/MS(n)) is one of
the most successful techniques for untargeted profiling of pa-
tient body fluids in order to identify small molecule metabo-
lites that correlate with, and are specific to, a given dis-
order and can thus be used as biomarkers. Another untargeted
approach is nuclear magnetic resonance (NMR) spectro-
scopy, though this technique is limited to metabolites that
are above the low micromolar (μM) range and is thus
blind to a significant portion of physiologically-relevant
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concentrations. LC/MS(n), on the other hand, is an ultrasensi-
tive technique and can routinely detect thousands of com-
pounds in a body fluid down to the low nanomolar (nM)
range, though it lacks the specificity to molecular structure
that is often necessary to distinguish isobaric compounds.
Thus, the techniques are complementary in the sense that
LC/MS(n) is very good at detecting mass/charge (m/z) features
in a sample that correlate with a particular disorder and NMR
is very good at identifying the molecular structures of un-
knowns. This is illustrated in the recent identification of a
new inborn error of metabolism (IEM), NANS deficiency
(van Karnebeek et al 2016). The metabolite identified as a
biomarker of the disease was detected by untargeted metabo-
lite screening using LC/QTOF-MS, where its concentration
was well within the sensitivity of the technique, but could
not be unambiguously identified from its structural analogues
on the basis of retention time, m/z ratio or fragmentation be-
havior. Thus, NMR was used to identify the molecular struc-
ture to correspond to N-acetylmannosamine by comparison to
reference material; however, it was close to the limits of sen-
sitivity for NMR. Thus, in order to push the limits of biomark-
er discovery, advances in analytical methods that combine
both extreme sensitivity and highly specific molecular struc-
ture information have a critical role. Here, we outline the po-
tential that infrared ion spectroscopy (IR-IS) has to fill such a
role in the state-of-the-art toolbox of metabolomics
researchers.
Infrared (vibrational) spectroscopy is a well-established
technique that is often used in the mid-IR region, or the vibra-
tional fingerprint region, to probe the fundamental vibrations
of molecules. This technique is often used, for example, in the
organic chemistry laboratory, to determine the presence or
absence of particular functional groups in a molecule in either
the solid, liquid or gas phase. This is possible because the IR
features of different functional groups are found at character-
istic (and very often unique) IR frequencies and make it pos-
sible to generate a fingerprint or signature of a particular mol-
ecule if a range of IR frequencies (for example, 1800–
600 cm−1) is sampled. These types of measurements are based
on detecting the extent of attenuation of the IR light after it
passes through a sample where photons are absorbed when
they are at resonant frequencies with one of the vibrations of
the molecule. Infrared ion spectroscopy (IR-IS) is the combi-
nation of ion trap mass spectrometry and infrared spectrosco-
py, selectively generating an IR spectrum for any mass-
isolated ion in the MS spectrum (see figures below). In con-
trast to the standard IR absorption spectroscopy described
above, IR-IS detects the absorption of IR photons on the basis
of the photofragmentation they induce in a set of precursor
ions trapped in a mass spectrometer. This approach exploits
the mass spectrometer as an extremely sensitive detector and
is necessary because the number densities of ions (of the same
charge) required to produce a measurable attenuation of the IR
light cannot be reached. Measurements are conducted directly
inside the mass spectrometer and thus maintain full sensitivity
and require no additional experiments outside of the mass
spectrometer. The IR spectrum of a given m/z feature, how-
ever, adds an orthogonal level of molecular structure informa-
tion in the form of an IR fingerprint. IR-IS has evolved in little
more than a decade from an experimental technique in aca-
demic labs studying fundamental molecular physics (Lemaire
et al 2002; Aleese et al 2006; Oomens et al 2006; Fridgen
2009; Polfer and Oomens 2009) to its current state, in which
it is a demonstrated (bio)analytical technique for the identifi-
cation of small molecules in complex mixtures (Martens et al
2017a, b), though still limited to user facilities or state-of-the-
art laboratories housing the most advanced tuneable infrared
laser technology. In the past decade, IR-IS has been used to
identify and characterize the molecular structures of many
classes of chemical compounds including amino acids
(Polfer et al 2005, 2006a; Correia et al 2008; Rodgers et al
2008; Oomens and Steill 2009; Scuderi et al 2011), nucleo-
tides and bases (Salpin et al 2007; Chiavarino et al 2013),
peptides and proteins (Balaj et al 2008; Polfer et al 2008;
Yoon et al 2008; Fukui and Takahashi 2012; Martens et al
2012, 2015, 2016a; Stedwell et al 2012; Scuderi et al 2015;
Dunbar et al 2017), saccharides (Martens et al 2017b; Polfer
et al 2006b; Cagmat et al 2010; Contreras et al 2012;
Schind le r e t a l 2014, 2017) , neuro t ransmi t t e r s
(Lagutschenkov et al 2010, 2011), and a variety of other main-
ly small organic compounds and reaction products (Martens
et al 2017a; MacAleese and Maître 2007; Rummel et al 2011;
De Petris et al 2013, 2016b; Warnke et al 2015; Cismesia et al
2016; Seo et al 2016; Schäfer et al 2017; Gorlova et al 2017).
Here we outline various ways IR-IS can currently be utilized
by the metabolomics community. As an example, we focus
largely on a biomarker of the IEM glutaric aciduria (GA),
glutaric acid, and an isobaric metabolite, ethylmalonic acid
(itself a biomarker for, among others, the IEM short-chain
acyl-CoA dehydrogenase deficiency, (SCAD)). As well, we
demonstrate an aspect of IR-IS that sets it apart from other
tandemMS techniques; IR spectra can accurately and routine-
ly be calculated in silico for entirely arbitrary molecular struc-
tures, unlocking the potential for reference standard free iden-
tification. As an additional example, we use a set of saccha-
rides to illustrate how IR-IS can be applied to identifying
enantiomeric compounds. Finally, in the same set of com-
pounds we show how functional group information can be
obtained for a complete unknown, which is valuable informa-
tion for, as an example, narrowing down a list of candidate
structures resulting from a database search result. This is es-
pecially relevant for the application of untargeted metabolo-
mics in body fluid samples in individual patients. In such
analyses many features occur that cannot be assigned by cur-
rent database searches thus hampering further progression of
such approaches in current clinical practice.
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IR-IS is a potentially valuable new approach to the chal-
lenge of identifying the many unknowns that arise from
untargeted metabolomics analyses of body fluids. Enabling
annotation of the most important Bunknown features^ in such
body fluid analyses may reveal previously unrecognized
IEMs and is critical for the field to make steps forward in
using untargeted metabolomics in research and diagnostics
of IEMs. This article shows that, in the view of the authors,
IR-IS is, already in its current state, a valuable and accessible
tool for molecular identification to the metabolomics commu-
nity and it outlines several paths forward to expand this role.
We discuss accessibility of the IR-IS technique both in terms
of sample submission to laboratories operating as international
user facilities, and possibilities arising from recent technolog-




All IR-IS measurements were performed in a modified quad-
rupole ion trap mass spectrometer (Bruker, amaZon Speed
ETD) coupled to the IR beam line of the FELIX free electron
laser. The FELIX laboratory (http://www.ru.nl/felix/) is an
international user facility and beam time is awarded through
calls for proposals. Details of hardware and software
modifications to the mass spectrometer have been reported
previously (Martens et al 2016c). Anonymized body fluid
samples were diluted to give analyte concentrations of ~10−7
M in order to sufficiently dilute the higher concentration com-
ponents of the sample. The diluted samples were directly
electrosprayed (+ESI, -ESI). Reference IR measurements were
generated from solutions of 10−7–10−8M (in 50:50 acetoni-
trile: H2O) of the appropriate reference standard. Reference
standards and electrospray solvents were obtained from
Sigma-Aldrich.
For these experiments, the FELIX free electron laser was
operated in the 600–1850 cm−1 range, giving 5 μs
macropulses (at a 10Hz repetition rate) of 30–60mJ per pulse
(bandwidth is ~0.4% of the center frequency). When the fre-
quency of the IR laser is resonant with a vibration in the
population of trapped ions absorption occurs and leads to an
increase in the internal energy of the ion. Facilitated by intra-
molecular vibrational redistribution of the absorbed energy,
the ions dissociate once they reach the limit of the dissociation
channel with the lowest barrier. Typically, after a single
macropulse, dissociation occurs providing a frequency-
dependent fragment ion m/z in the mass spectrum. By relating
the parent and fragment ion intensities (yield =ΣI (fragment
ions)/ΣI (all ions)) to the IR frequency, an infrared spectrum is
generated. The yield at each IR point is obtained from four to
eight averaged mass spectra and is linearly corrected for laser
power. Note that the FELIX pulse energy can be decreased
with calibrated attenuators in order to prevent complete deple-
tion of the parent ion population. The frequency is calibrated
online using a grating spectrometer.
Quantum chemical calculations
Molecular structures manually defined (based on chemical
intuition and known gas-phase ion chemistry) were optimized
for each ion of interest at the MP2/aug-cc-pVDZ level in the
commercially available software package Gaussian09 (Frisch
et al 2009). For each optimized molecular geometry,
anharmonic vibrational frequencies were computed and are
presented unscaled. Infrared absorption lines were broadened
using a Gaussian line shape of (FWHM 25 cm−1) to facilitate
comparison with the experimental spectra.
Results
Glutaric acid and ethylmalonic acid are two well-known small
organic acid metabolites (depicted in Fig. 1) that can be ion-
ized in both positive and negative mode electrospray ioniza-
tion (+ESI, -ESI) by protonation or deprotonation,
respectively.
Distinguishing these two compounds using standard
reversed-phase HPLC/(tandem)MS is a challenge as both their
retention times and their MS/MS fragmentation behavior are
very similar. Using reference standards for these two com-
pounds, we have generated IR spectra of both their
deprotonated and protonated ions in order to explore potential
differences arising from the different structures and gas-phase
conformations, illustrated in panels I and II of Fig. 2, respec-
tively. In both cases, the ions of the two compounds are clearly
distinguishable by IR-IS, however, we observe relatively
broad bands that are not very clearly resolved in terms of
frequency, especially for the deprotonated ions (panel I).
The gas-phase conformations of these protonated/
deprotonated diacids likely involves a hydrogen bond be-
tween the ionized acid group and the neutral group. The
Fig. 1 Structures of isobaric metabolites ethylmalonic acid and
glutaric acid. These compounds are dicarboxylic acids differing by the
branched or linear group connecting the two acid moieties
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difference in length of the carbon backbone connecting the
two acid groups will influence the nature of the interaction
between the two groups, especially upon ionization, in which
case the interaction becomes stronger. This effect has a clear
influence on the IR spectra, illustrated in Fig. 2 (panels I and
II), though in both cases all spectra exhibit quite broad peaks
that are not well resolved from each other. In order to gain a
second-level identification of these two compounds we can do
MS/MS fragmentation of the precursor ions (shown here for
only the protonated ions, m/z 133 in both cases) and re-isolate
one of the dominant fragments, in this case loss of neutral H2O
(mass 18). Subsequently, we measured the IR spectra of the
isolated fragment ions (m/z 115 in both cases). These results
are presented in panel III, showing again clear distinction be-
tween the glutaric acid-derived fragment ion (black) and its
ethylmalonic acid derived analogue. In this case, however, we
observe clearly different IR spectra for the two ions, both
exhibiting sharp and well resolved bands over the entire vi-
brational fingerprint region (600–1900 cm−1), with multiple
frequencies that are resonant with vibrations in only one spe-
cies and thus independently diagnostic.
Having demonstrated the distinction on the basis of IR
fingerprints of the two isobaric diacids above from refer-
ence standards, we are able to identify unknowns from a
sample using the generated reference IR spectra. GA is an
IEM for which glutaric acid is a known biomarker and is
found in highly elevated levels in patients. In all four
panels of Fig. 3, reference IR spectra of the four glutaric
acid derived ions are overlaid with IR spectra of ions
having corresponding m/z values after ESI of a urine sam-
ple from a GA patient, identifying glutaric acid as a bio-
marker on the basis of four IR fingerprints (four different
m/z features all derived from glutaric acid).
Details of molecular structure through calculated IR
spectra and gas phase ion chemistry
The comparison of IR spectra for the collision induced
dissociation (CID) fragments in panels III and IV of Fig.
3 in both cases allow assignment of matching fragment
ion structures and thus provide additional weight to the
precursor ion assignment as glutaric acid (protonated and
deprotonated, respectively). However, the measured IR
spectra of these fragment ions alone do not reveal their
molecular structures, only the presence of particular func-
tional groups (for example, bands around 1700 cm−1
Fig. 2 Various IR spectra of glutaric acid and ethylmalonic acid.
Panel I presents the IR spectra of deprotonated glutaric acid (m/z 131
black) and ethylmalonic acid (m/z 131, blue). Panel II presents the IR
spectra of protonated glutaric acid (m/z 133, black) and ethylmalonic acid
(m/z 133, red). Panel III presents the IR spectra of the re-isolated CID
fragments (in both cases m/z 115, neutral loss of mass 18 - H2O) from
protonated glutaric acid (black) and ethylmalonic acid (red)
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indicate a carbonyl group in the structure). Using chemi-
cal intuition, the fragmentation mechanism (correspond-
ing to loss of mass 18, i.e., loss of H2O) can be hypoth-
esized and IR spectra can be quantum chemically calcu-
lated for arbitrary candidate fragment structures. These
predicted IR spectra, when matched to the measured spec-
tra, can be used to assign molecular structures to the frag-
ment ions. This comparison is presented in Fig. 4, where
we assign ring-closed anhydride structures to the frag-
ments originating from glutaric acid and a ketene/
carboxylic acid structure from ethylmalonic acid. These
structures are as well consistent with the length of the
carbon chain connecting the two acid groups in the
respective precursors, as a ring-closed structure is hardly
possible to form from ethylmalonic acid.
As an example of how molecular structure/conformation
information can be extracted by comparison to calculated IR
spectra and their corresponding calculated structures, we fo-
cus here on the carbonyl stretching frequency range between
1600 and 1850 cm−1 for a detailed analysis. Panel I of Fig. 4
presents the calculated and experimental IR spectra of the m/z
113 CID fragment (precursor m/z 131 assigned as
deprotonated glutaric acid from a GA patient sample) with
the assigned structure inlayed. In this structure, the carbonyl
groups are not equivalent due to deprotonation occurring on
the carbon atom adjacent to one of them (indicated with B*^).
Fig. 3 IR spectra of four
glutaric acid derived ions and
IR spectra of the corresponding
m/z features from a urine
sample of a patient with GA.
Above the figure, the full MS
spectrum in +ESI mode of the GA
sample. An ion at m/z 133 is
identified, mass isolated, and
trapped in the MS. In this manner,
IR-IS generates mass-selective IR
spectra for any ion observed in an
MS or MS/MS (not schematically
illustrated here) spectrum. Panel I
presents the IR spectra of
protonated glutaric acid (m/z 133
black) and m/z 133 from a GA
patient sample (red). Panel II
presents the IR spectra of
deprotonated glutaric acid (m/z
131, black) and m/z 131 from a
GA patient sample (red). Panel III
presents the IR spectra of the re-
isolated CID fragment (m/z 115,
neutral loss of mass 18) from
protonated glutaric acid (black)
and m/z 115, neutral loss of mass
18 from m/z 133 from a GA
patient sample (blue). Panel IV
presents the IR spectra of the re-
isolated CID fragment (m/z 113,
neutral loss of mass 18) from
deprotonated glutaric acid (black)
and m/z 113, neutral loss of mass
18 from m/z 131 from a GA
patient sample (blue)
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This results in a strengthening of the C=O bond which shifts
one stretching vibration to a higher frequency, splitting the
two carbonyl stretching vibrations at approximately 1740 vs.
1675 cm−1. Panel II is an analogous comparison of the calcu-
lated and experimental spectra for the m/z 115 CID fragment
(precursor m/z 133 assigned as protonated glutaric acid from
GA patient sample) with the assigned structure once again
inlayed. In this structure, protonation occurs on one carbonyl
group (indicated with a B*^), causing a shift to lower frequen-
cy of the protonated C=O stretching vibration (~1630 cm−1)
due to a weakening of the C=O bond. The carbonyl that is not
protonated is correspondingly strengthened and shifted to
higher frequency (outside of the range probed in this particular
experiment and thus unobserved, ~2120 cm−1). Panel III pre-
sents two calculated IR spectra proposed for the m/z 115 CID
fragment (precursor m/z 133 assigned as protonated
ethylmalonic acid from SCAD patient sample) with the
corresponding calculated molecular structures inlayed. In this
case, two orientations of the carboxyl group are possible, one
in which the carbonyl oxygen interacts with the carbon of the
ketene group and the other in which the group is rotated by
~180 degrees and the carbonyl is free from intramolecular
interaction. The presence of these two conformations in the
trapped ion population causes a splitting of the C=O stretching
vibration where the free C=O stretch is found shifted to higher
frequency (~1840 vs. 1780 cm−1). In both conformations the
ketene C=O is shifted to much higher frequency (~2200 cm−1)
and is unobserved in the frequency range scanned in these
experiments. Panel IV presents the calculated IR spectra of
the two conformations combined in a 50:50 ratio in shaded
red, together accounting for the experimental IR spectrum of
the m/z 115 CID fragment (from the m/z 133 precursor ion
from the SCAD sample) and providing a convincing second
level signature of ethylmalonic acid in the SCAD sample. We
Fig. 4 Identification of
molecular structures on the
basis of comparison to
calculated reference IR spectra.
Panel I presents the IR spectrum
of the m/z 113CID fragment from
m/z 131 from a urine sample of a
GA patient (-ESI) compared to
the calculated IR spectrum (shad-
ed gray) predicted for a candidate
structure corresponding to
deprotonated glutaric anhydride
(structure inlayed). Panel II pre-
sents the IR spectrum of the m/z
115 CID fragment from m/z 133
from a urine sample of a GA pa-
tient (+ESI) compared to the cal-
culated IR spectrum (gray) pre-
dicted for a candidate structure
corresponding to protonated
glutaric anhydride (structure
inlayed). Panel III presents two
calculated IR spectra correspond-
ing to two gas phase conforma-
tions of a ketene/acid fragment
structure for the m/z 115 CID
fragment from m/z 133 from a
urine sample of a SCAD patient.
Panel IV presents the IR spectra
from panel II combined and
compared to the experimental IR
spectrum for the m/z 115 CID
fragment from the SCAD sample
m/z 133 precursor ion. The cal-
culated spectrum of the isobaric
fragment shown in panel II is also
compared (gray shaded) showing
clear mismatch.^*Bs in all struc-
tures indicate the site of proton-
ation/deprotonation
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note that by confirming the different molecular structures of
the CID fragments resulting from H2O loss from glutaric acid
and ethylmalonic acid, additional confirmation of the precur-
sor ion structures is obtained.
There are several criteria by which we assign a calculated IR
spectrum to be a Bmatch^ to the experimental one. The output
of an IR spectrum calculation is a line spectrum (peak positions
without any defined broadening). This makes the alignment of
peak center positions between experiment and theory the most
important criteria instead of the peak area (to facilitate compar-
ison with experiment we impose a broadening of ~25 cm−1
using a Gaussian line shape of the calculated line spectra).
Calculated intensities correspond only to the process of a single
IR photon absorption, whereas we use multiple photon disso-
ciation to detect IR photon absorption. As a result, correlation
between calculated IR absorption intensities and observed ex-
perimental IR dissociation yields can deviate, though often still
match favorably. In panel IVof Fig. 4, the calculated IR spec-
trum of the protonated anhydride m/z 115 fragment from panel
II is included as a gray trace. Though corresponding to an
isobaric ion structure with similar functionality, clear distinction
is observed in comparison to the IR spectra of the m/z 115
fragment from the SCAD sample (red line).
Discussion
Identification of functional groups
Figure 5 presents a comparison of IR spectra of the phosphor-
ylated hexoses, glucose and galactose, distinguishing phos-
phorylation in the 1 position or 6 position in both +ESI (top
panels) and –ESI (bottom panels). In all IR spectra, the intense
feature between ~1200–1300 cm−1 is dominated by vibrations
of the phosphate functional groups (compared to the IR
spectra in Fig. 6 for two sets of saccharides that are not
phosphorylated). Clearly, the position of the phosphorylation
has an effect on the gas-phase conformations of these ions that
results in significant differences in their IR spectra, making
them readily distinguishable. Figure 6 compares, in panel I,
the IR spectra of N-acetylgalactosamine and N-
acetylmannosamine and in panel II the IR spectra of two
unfunctionalized disaccharides, lactose and maltose. In addi-
tion to distinguishing these challenging sets of isobaric metab-
olites, we can also attribute specific IR spectral features to
particular functional groups within these different classes of
saccharides. For the N-acetylhexosamines, two bands above
1400 cm−1 (~1500 cm−1 is the C-N vibration and ~1650 cm−1
Fig. 5 IR spectra of
phosphorylated glucose and
galactose. Panels I and II
compare the IR spectra of glucose
1- and 6-phosphate and galactose
1- and 6-phosphate in +ESI as
singly charged protonated
disodium ions. Panels III and IV
compare the IR spectra of glucose
1- and 6-phosphate and galactose
1- and 6-phosphate in –ESI as
singly charged deprotonated ions
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is the C=O stretch) are present that are absent for
unfunctionalized saccharides and phosphorylated saccharides.
In Fig. 5, as noted above, a very intense feature between 1200
and 1300 cm−1 (bands of the phosphate group) is observed
that is absent in the IR spectra for both classes of saccharides
presented in Fig. 6. Information on the functional groups pres-
ent in amolecule, while not sufficiently specific to identify full
molecular structures, provides clues on features of molecular
structure that are useful when, for example, a database search
returns multiple isobaric candidate structures.
Accessibility and database potential
At the moment, only a few laboratories worldwide have
both the MS and mid-IR laser infrastructure to conduct
analytical IR-IS experiments. This is largely related to
the fact that a majority of the published IR-IS studies have
utilized IR free electron lasers (IR-FEL), which are of
limited availability. Until recently, alternative mid-IR laser
sources, such as optical parametric oscillators (OPO),
have only been available with relatively low output power
and limited tuning ranges, somewhat limiting their scope
of application, though examples of their application to
metabolite identification do exist (Martens et al 2017a,
b; Gorlova et al 2017). Nevertheless, several IR-FEL fa-
cilities (including FELIX) are currently open to external
researchers. In addition, with the quickly advancing de-
velopment of new mid-IR laser sources (such as quantum
cascade lasers), the possibilities for benchtop IR-IS tech-
niques in state-of-the-art analytical laboratories specializ-
ing in small molecule identification is continually moving
ahead. This is especially true for applications that do not
require large laser tuning ranges, such as targeted screen-
ing experiments. Recent advances in table-top IR lasers
produced commercially available IR-IS suitable lasers ca-
pable of tuning over ~10–200 cm−1 centered anywhere in
the vibrational fingerprint region (600–3800 cm−1). To
facilitate developments in this directly, our group is pur-
suing the inclusion of IR-IS generated IR spectra for a
series of well-known challenging isobaric metabolites in
the human metabolome database (HMDB) (Wishart et al
2013). The first sets of isobaric metabolites we generated
IR spectra for to be included in the database are presented
in Table 1. These results illustrate the wide range of
chemical compounds that are distinguishable by their IR
spectra. Including full reference IR spectra (generated
using the IR-FEL) over the entire vibrational fingerprint
region will certainly guide the advance of IR-IS using
table-top infrared lasers with limited tuning range in the
future by identifying spectral regions that are selective to
one (or a set of) metabolite ion(s). A feature of IR spec-
troscopy is that vibrational line positions (peak centers)
for an arbitrary molecule are closely reproducible irre-
spective of the experimental apparatus that is used (MS
or IR laser). This makes IR spectra valuable chemical
properties for inclusion in the HMDB as the reproducibil-
ity of IR-IS measurements has the potential to be favor-
able between labs. Infrared spectroscopy primarily probes
functional groups and is highly-sensitive to variations in
intramolecular interactions. For an unknown mass peak,
some basic chemical information (functional groups) can
be directly inferred. In an approach similar to the conven-
tional application of IR spectroscopy in organic chemistry,
bands at specific wavelengths can be tied to the presence
of certain functional groups. For example, a vibrational
peak between 1750 cm−1 and 2000 cm−1 is indicative of
a carbonyl group, as well as that it is not involved in an
intramolecular hydrogen bond; the presence of OH and
NH groups can be readily identified by the stretching
vibrations between 2900 and 3800 cm−1. This information
can be of significant value when one considers multiple
candidate structures from a database search related to an
unknown m/z feature. Additionally, by demonstrating ex-
amples of metabolites that are challenging to distinguish
by standard LC/MS approaches, but distinguishable by
Fig. 6 Comparison of the IR spectra of different saccharides. Panel I
compares the IR spectra of N-acetylated mannose and galactose as
sodium adducts in +ESI. Panel II compares the IR spectra of the
unfunctionalized disaccharides lactose and maltose as chloride adducts
by –ESI
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IR-IS, researchers worldwide can submit applications for
IR-IS experiment time at IR-FEL user laboratories for
measurements that will answer their specific research
questions.
Of course, the database potential of an experimental dataset
depends highly on reproducibility. Figure 7 illustrates the fa-
vorable reproducibility of IR-IS measured peak areas (better
than 97%), over two repeated scans (such reproducibility has
previously been demonstrated throughout the nM to mM con-
centration range (Martens et al 2017b)). Note that by consid-
ering the fragmentation yield as the IR intensity (see Methods
section), we compare the fraction of ions that dissociate at
each frequency point, making the measurements independent
of the total ion count and hence of concentration. Currently,
the measurement of one IR spectrum typically takes ~10 min
using ESI flow rates of ∼2 μL/min. At nM concentrations, this
corresponds to sample consumption on the order of a few
nanograms per IR spectrum.
Outlook
A number of groups, including our own at the FELIX labora-
tory, are actively pursuing the combination of mass spectrom-
etry and IR spectroscopy as an analytical tool (Martens et al
2017a, b; Cismesia et al 2016; Gorlova et al 2017). In our
group, this work is currently focused on the following three
primary objectives: 1) optimizing the efficiency of IR spectra
acquisition so that an IR spectrum (perhaps over a limited spec-
tral range of a few hundred wavenumbers) can be acquired in
less than several 10s of seconds, 2) optimizing the sensitivity of
themass spectrometry aspect of the IR-IS experiment (currently
low nanomolar for setups based on commercial MS platforms)
Table 1 Illustrative examples of metabolites for which IR spectra have been measured using the IR-IS technique at the FELIX Laboratory
MW (neutral) Compound Source Class ID by IR-IS?
organic acids ✓
1 168.1467 3,4-dihydroxyphenylacetic acid secondary to medication
2 168.1467 2,5-dihydroxyphenylacetic acid alkaptonuria
N-acetylhexosamines ✓ (Martens et al 2017b)
3 221.2078 N-acetylglucosamine metabolite
4 221.2078 N-acetylgalactosamine metabolite
5 221.2078 N-acetylmannosamine NANS-deficiency
acylglycines ✓
6 207.2258 N-acetyl-L-phenylalanine PKU
7 207.2258 phenylpropionylglycine MCAD
prostaglandins ✓
8 352.4651 prostaglandin E2 metabolite
9 352.4651 prostaglandin D2 metabolite
organic acids ✓
10 118.088 methylmalonic acid MMA
11 118.088 succinic acid metabolite, oncometabolite
organic acids ✓
12 132.1146 ethylmalonic acid SCAD
13 132.1146 glutaric acid GA(T1)
phosphosaccharides ✓
14 260.1358 glucose 1-phosphate metabolite
15 260.1358 glucose 6-phosphate metabolite
16 260.1358 galactose 1-phosphate metabolite
17 260.1358 galactose 6-phosphate metabolite
disaccharides ✓
18 342.2965 lactose metabolite
19 342.2965 maltose metabolite
statins ✓ (Martens et al 2017a)
20 574.6392 ortho-hydroxyatorvastatin drug metabolite
21 574.6392 para-hydroxyatorvastatin drug metabolite
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for maximum possible coverage of physiologically relevant
concentrations, and 3) combining all aspects of the IR-IS ex-
periment together with HPLC protocols for the routine analysis
of complex mixtures such as bio-fluids. Our group has recently
demonstrated advances in sensitivity and efficiency that com-
bine IR-IS with offline (fraction collection) HPLC (Martens
et al 2017a) and are actively pursuing online HPLC/IR-IS
schemes using either a stop flow approach or piecewise spectral
acquisition of several hundred wavenumber (cm−1) intervals
over the desired spectral domain.
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